The Valley Desk

NCT07116967 · Interventional trial

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Overall registry status Recruiting

Phase 3

Conditions Plaque Psoriasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov